engleski

Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism

This retrospective single-center study on a large cohort of hospitalized patients (n=5876) with coronavirus disease 2019 (COVID-19) investigated the impact of baseline platelet counts on different disease-related outcomes. Patients with COVID-19 and higher baseline platelet counts had less respiratory deterioration, better overall survival, but higher risk of thrombosis. These interesting results provide new insights into the the biology of thrombosis in COVID-19 patients.

thrombocytosis ; COVID-19 ; myeloproliferative neoplasms ; prognosis ; venous thromboembolism

nije evidentirano